Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Alnylam Pharmaceuticals (ALNY)

Alnylam Pharmaceuticals (ALNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Stocks Recover as Data Storage Companies and Chip Makers Rally

The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.16%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.17%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.08%. March E-mini S&P...

AMAT : 318.23 (-2.68%)
B : 50.01 (+2.63%)
AVGO : 332.60 (-5.43%)
C : 112.80 (-4.44%)
HL : 28.24 (+6.41%)
HSIC : 77.73 (-2.81%)
CDE : 22.87 (+1.28%)
JPM : 302.74 (-3.11%)
AKAM : 89.60 (-4.16%)
ANIP : 85.77 (+1.11%)
$IUXX : 24,987.57 (-2.12%)
UNH : 338.43 (+2.24%)
Equity Indexes Recover Early Losses as Precious Metals Reach New Record Highs

The S&P 500 Index ($SPX ) (SPY ) today is up +0.28%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.15%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.55%. After opening lower, stock indexes...

B : 50.01 (+2.63%)
C : 112.80 (-4.44%)
HL : 28.24 (+6.41%)
HSIC : 77.73 (-2.81%)
CDE : 22.87 (+1.28%)
JPM : 302.74 (-3.11%)
AKAM : 89.60 (-4.16%)
ANIP : 85.77 (+1.11%)
$IUXX : 24,987.57 (-2.12%)
UNH : 338.43 (+2.24%)
ZNH26 : 111-180 (+0.13%)
MA : 531.74 (-1.44%)
Alnylam Launches “Alnylam 2030” Strategy to Drive Next Era of Growth and Patient Impact

− Full Year 2025 Preliminary* Net Product Revenues of $2,987 Million (81% Growth vs. 2024), Driven Primarily by Preliminary* Total TTR Revenues of $2,487 Million (103% Growth vs. 2024) – ...

ALNY : 355.53 (-1.04%)
Alnylam to Webcast Presentation at 44th Annual J.P. Morgan Healthcare Conference

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present a company overview and participate in a Q&A session at the 44 ...

ALNY : 355.53 (-1.04%)
Stocks Slip as Bond Yields Rise

The S&P 500 Index ($SPX ) (SPY ) today is down -0.12%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.11%. March E-mini S&P futures...

C : 112.80 (-4.44%)
RARE : 22.63 (+0.62%)
SLB : 46.45 (-0.60%)
$IUXX : 24,987.57 (-2.12%)
ZNH26 : 111-180 (+0.13%)
OXY : 42.24 (-1.08%)
ESH26 : 6,854.00 (+0.36%)
FANG : 148.70 (-1.71%)
$DOWI : 48,488.59 (-1.76%)
SPY : 677.58 (-2.04%)
DIA : 484.88 (-1.73%)
INSM : 163.51 (+1.29%)
Alnylam to Invest $250 Million to Add Enzymatic Ligation Platform to U.S. Manufacturing Facility to Meet Growing Global Demand for RNAi Therapeutics

New platform is expected to substantially increase manufacturing capacity and lower production costs, enabling investment in expanding pipeline FDA has accepted Alnylam’s enzymatic ligation...

ALNY : 355.53 (-1.04%)
Alnylam Announces Partial Repurchase of 1.00% Convertible Senior Notes Due 2027

Alnylam Pharmaceuticals, Inc. (“Alnylam”) (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that it has entered into separate, privately negotiated repurchase agreements with certain...

ALNY : 355.53 (-1.04%)
Alnylam Pharmaceuticals Announces Changes to Board of Directors

– Mike Bonney and Carolyn Bertozzi to Depart; Company Appoints Stuart Arbuckle as New Independent Director –

ALNY : 355.53 (-1.04%)
Is Vertex Pharmaceuticals Stock Underperforming the Nasdaq?

Vertex Pharmaceuticals has underperformed the broader Nasdaq index over the past year. However, Wall Street analysts remain moderately optimistic about its prospects.

$NASX : 22,954.32 (-2.39%)
VRTX : 442.08 (+0.16%)
ALNY : 355.53 (-1.04%)
The Biotech Boom Gets a Trading Tool: How Direxion's Titans ETF Gives Access to the Sector's Top Performers

Amid the biotechnology sector's transformative era the Direxion Daily Biotech Top 5 Bull 2X ETF ($TBXU) offers traders a new, single-trade solution to gain 2X daily leveraged exposure to an e

ALNY : 355.53 (-1.04%)
EXEL : 43.78 (-0.41%)
GILD : 124.14 (-0.62%)
INSM : 163.51 (+1.29%)
UTHR : 468.07 (+0.68%)

Barchart Exclusives

Trump’s Greenland Threats Scaring You Off? Buy This Dividend Stock as a Hedge
Trump's threats to seize Greenland have led to a selloff in risk assets while precious metals have rallied amid the flight to safe-haven assets. Agnico-Eagle Mines is a good dividend stock to buy amid the geopolitical turmoil. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar